Reply to Keyon

Journal Article Accepted manuscript Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation Get access Aniruddha Hazra, Aniruddha Hazra Section of Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, IL, USAHoward Brown Health, Chicago, IL, USA CORRESPONDING AUTHOR: Aniruddha Hazra, MD, 5841 S. Maryland Avenue, MC5065; Chicago, IL 60637, ahazra2@bsd.uchicago.edu https://orcid.org/0000-0001-8557-4465 Search for other works by this author on: Oxford Academic PubMed Google Scholar Connie Celum, Connie Celum Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne F Luetkemeyer, Anne F Luetkemeyer Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, CA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Jean-Michel Molina, Jean-Michel Molina University of Paris Cité, Saint-Louis and Lariboisière Hospitals, Assistance Publique Hopitaux de Paris, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Jeffrey D Klausner Jeffrey D Klausner Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae152, https://doi.org/10.1093/cid/ciae152 Published: 19 March 2024 Article history Received: 28 February 2024 Accepted: 11 March 2024 Published: 19 March 2024